5 Year Outcomes after Proton Therapy for Treatment of High-Risk Neuroblastoma (HR-NBL)

被引：0
|
作者：
Hill-Kayser, C. [1 ,2 ]
Balamuth, N. [3 ]
Womer, R. [3 ]
Maris, J. [3 ]
Mosse, Y. [3 ]
Fox, E. [3 ]
Balis, F. [3 ]
Grupp, S. [3 ]
Miller, A. [3 ]
Kurtz, G. [1 ,2 ]
Lustig, R. [1 ,2 ]
Tochner, Z. [1 ,2 ]
Bagatell, R. [3 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Radiat Oncol, Philadelphia, PA USA
[3] Childrens Hosp Philadelphia, Oncol, Philadelphia, PA 19104 USA
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-088
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma
    Hill-Kayser, Christine E.
    Tochner, Zelig
    Li, Yimei
    Kurtz, Goldie
    Lustig, Robert A.
    James, Paul
    Balamuth, Naomi
    Womer, Richard
    Mattei, Peter
    Grupp, Stephen
    Mosse, Yael P.
    Maris, John M.
    Bagatell, Rochelle
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (02): : 401 - 408
  • [2] Strategic Dietetic Intervention for Children Following the High Risk Neuroblastoma Treatment Protocol (HR-NBL 1/SIOPEN)
    Upton, L.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S283 - S283
  • [3] Organ Motion in Pediatric High-Risk Neuroblastoma (HR-NBL) Patients Using 4-Dimensional Computed Tomography (4DCT)
    Kannan, S.
    Teo, B. K.
    Solberg, T. D.
    Hill-Kayser, C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E555 - E556
  • [4] EFFICACY & TOXICITY OF EXTERNAL BEAM RADIOTHERAPY (EBRT) FOR METASTATIC SITES (MS) PRESENT AT END INDUCTION (EI) IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA (HR-NBL)
    Hill-Kayser, Christine
    Kurtz, Goldie
    Balamuth, Naomi
    Lustig, Robert
    Balis, Frank
    Macfarland, Suzanne
    Batra, Vandana
    Mosse, Yael
    Maris, John
    Mostoufi-Moab, Sogol
    Ginsberg, Jill
    Bagatell, Rochelle
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S184 - S184
  • [5] Success of the HR-NBL/SIOPEN local control trial strategy in high risk neuroblastoma patients undergoing high dose therapy with peripheral stem cell transplantation
    Ladenstein, Ruth
    Poetscher, Ulrike
    Luksch, Roberto
    Castel, Victoria
    Yaniv, Isaac
    Papadakis, Vassilios
    Laureys, Genevieve
    Malis, Josef
    Balwierz, Walentyna
    Ruud, Ellen
    Kogner, Per
    Schroeder, Henrik
    de Lacerda, Ana Forjaz
    Beck-Popovic, Maja
    Bician, Pavel
    Garami, Miklos
    Trahair, Toby
    Canete, Adela
    Ambros, Peter
    Holmes, Keith
    Garaventa, Alberto
    Michon, Jean
    Pearson, Andrew
    Valteau-Couanet, Dominique
    Gaze, Mark
    Botterberg, Tom
    BONE MARROW TRANSPLANTATION, 2018, 53 : 128 - 129
  • [6] Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study
    Morgenstern, Daniel A.
    Poetschger, Ulrike
    Moreno, Lucas
    Papadakis, Vassilios
    Owens, Cormac
    Ash, Shifra
    Pasqualini, Claudia
    Luksch, Roberto
    Garaventa, Alberto
    Canete, Adela
    Elliot, Martin
    Wieczorek, Aleksandra
    Laureys, Genevieve
    Kogner, Per
    Malis, Josef
    Ruud, Ellen
    Beck-Popovic, Maja
    Schleiermacher, Gudrun
    Valteau-Couanet, Dominique
    Ladenstein, Ruth
    PEDIATRIC BLOOD & CANCER, 2018, 65 (11)
  • [7] RESULTS OF AN INTENSIVE INDUCTION PROTOCOL FOR HIGH-RISK NEUROBLASTOMA IN MOROCCO (HR-NBL-MA-10)
    Khattab, M.
    Elkababri, M.
    Cherkaoui, S.
    Benmiloud, S.
    ElHoudzi, J.
    Hessissen, L.
    Lam, C.
    Parikh, N.
    Howard, S.
    Matthay, K.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S106 - S106
  • [8] Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial
    Ladenstein, R. L.
    Poetschger, U.
    Luksch, R.
    Brock, P.
    Castel, V.
    Yaniv, I.
    Papadakis, V.
    Laureys, G.
    Malis, J.
    Balwierz, W.
    Ruud, E.
    Kogner, P.
    Schroeder, H.
    De Lacerda, A. Forjaz
    Popovic, M. Beck
    Bician, P.
    Garami, M.
    Trahair, T.
    Pearson, A. D.
    Couanet, D. Valteau
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [9] Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
    Garaventa, Alberto
    Poetschger, Ulrike
    Valteau-Couanet, Dominique
    Luksch, Roberto
    Castel, Victoria
    Elliott, Martin
    Ash, Shifra
    Chan, Godfrey C. F.
    Laureys, Genevieve
    Beck-Popovic, Maja
    Vettenranta, Kim
    Balwierz, Walentyna
    Schroeder, Henrik
    Owens, Cormac
    Cesen, Maja
    Papadakis, Vassilios
    Trahair, Toby
    Schleiermacher, Gudrun
    Ambros, Peter
    Sorrentino, Stefania
    Pearson, Andrew D. J.
    Ladenstein, Ruth Lydia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2552 - +
  • [10] SHORT (STI) AND LONG TERM INFUSION (LTI) OF CH14.18/CHO IMMUNOTHERAPY: TOXICITY PROFILES AND OUTCOMES IN 530 HIGH RISK NEUROBLASTOMA (HR-NBL) PATIENTS IN TWO SIOPEN TRIALS
    Ladenstein, R.
    Poetschger, U.
    Gray, J.
    Couanet, D. Valteau
    Luksch, R.
    Castel, V.
    Yaniv, I.
    Laureys, G.
    Elliott, M.
    Michon, J.
    Owens, C.
    Trahair, T.
    Chan, G. Chi Fung
    Ruud, E.
    Schroeder, H.
    Popovic, M. Beck
    Glogova, E.
    Schreier, G.
    Loibner, H.
    Lode, H.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S145 - S145
12345